F. Ceccacci et al. / Tetrahedron: Asymmetry 21 (2010) 2117–2123
2123
6a. 1H NMR (CDCl3): 6.804 (4H, s, Ar); 3.881 (4H, t, ArOCH2–,
J = 6.5 Hz); 3.627 (4H, t, –CH2OH, J = 6.5 Hz); 1.80–1.64 (4H, m, Ar-
OCH2CH2–); 1.62–1.15 (36H, m, –(CH2)9–). 13C NMR (CDCl3):
153.20; 115.40; 68.67; 63.13; 32.83; 29.58; 29.41; 26.07; 25.76.
3.22–3.06 (1H, m, CH2N), 3.02–2.86 (1H, m, CH2N), 2.86–2.66
(1H, m, d), 2.40–2.05 (2H, m, b), 2.04–1.86 (2H, m, c), 1.82–1.60
(4H, m, ArOCH2CH2, CH2CH2N), 1.48–1.08 (16H, m, –(CH2)8). 13C
NMR (CDCl3): 170.20, 159.05, 129.37, 120.40, 114.41, 69.88,
67.78, 55.82, 54.89, 29.53, 29.49, 29.44, 29.38, 29.26, 29.17,
26.76, 26.04, 25.89, 23.59.
3.5.8. 12-[4-(11-Formyl-undecyloxy)-phenoxy]-dodecanal 7c
Compound 7c, a white solid, was obtained from 6c in 70% yield
after purification (column chromatography, CHCl3), and following
the same procedure described for 7a. 1H NMR (CDCl3): 9.745 (2H,
t, –CHO, J = 1.7 Hz); 6.801 (4H, s, Ar); 3.878 (4H, t, ArOCH2–,
J = 6.6 Hz); 2.406 (4H, dt, –CH2CHO, J = 7.3 Hz, J = 1.7 Hz); 1.84–
1.51 (8H, m, ArOCH2CH2, –CH2CH2CHO), 1.50–1.18 (28H, m, –
(CH2)7–). 13C NMR (CDCl3): 202.96; 153.14; 136.53; 115.32;
68.58; 43.88; 29.50; 29.46; 29.37; 29.31; 29.28; 29.23; 29.11;
26.01; 22.04.
Acknowledgments
We acknowledge the financial support from FIRB, Research pro-
gram: Ricerca e Sviluppo del Farmaco (CHEM-PROFARMA-NET),
Grant no. RBPR05NWWC 003 and from Dipartimento di Progettaz-
ione Molecolare. This work was carried out in the frame of CM0703
‘Systems Chemistry’ COST Action.
References
3.5.9. (2S)-1-[12-(4-{12-[(2S)-2-Carboxypyrrolidine-1-yl]dodecyl-
oxy}phenoxy)dodecyl]pyrrolidine-2-carboxylic acid 2c
1. (a) De Rosa, M.; Gambacorta, A.; Gliozzi, A. Microbiol. Rev. 1986, 50, 70–80; (b)
De Rosa, M.; Gambacorta, A. Prog. Lipid Res. 1988, 27, 153–175; (c) Gambacorta,
A.; Gliozzi, A.; De Rosa, M. World J. Microbiol. Biotechnol. 1995, 11, 115–131; (d)
Gliozzi, A.; Relini, A.; Lee Gau Chong, P. J. Membr. Sci. 2002, 206, 131–147.
2. (a) Mc Kenzie, D. C.; Bunton, C. A.; Nicoli, D. F.; Savelli, G. J. Phys. Chem. 1987, 91,
5709–5713; (b) Fuhrhop, J. H.; Mathieu, J. Chem. Commun. 1983, 144–145; (c)
Fuhrhop, J. H.; Wang, T. Chem. Rev. 2004, 104, 2901–2937; (d) Meister, A.;
Blume, A. Curr. Opin. Colloid Interface Sci. 2007, 12, 138–147; (e) Yan, Y.; Lu, T.;
Huang, J. J. Colloid Interface Sci. 2009, 337, 1–10. and reference cited therein.
3. (a) Alzalamira, A.; Ceccacci, F.; Monti, D.; Levi Mortera, S.; Mancini, G.; Sorrenti,
A.; Venanzi, M.; Villani, C. Tetrahedron: Asymmetry 2007, 18, 1868–1876; (b)
Borocci, S.; Ceccacci, F.; Galantini, L.; Mancini, G.; Monti, D.; Scipioni, A.;
Venanzi, M. Chirality 2003, 15, 441–447; (c) Ceccacci, F.; Diociaiuti, M.;
Galantini, L.; Mancini, G.; Mencarelli, P.; Scipioni, A.; Villani, C. Org. Lett. 2004,
6, 1565–1568; (d) Ceccacci, F.; Mancini, G.; Sferrazza, A.; Villani, C. J. Am. Chem.
Soc. 2005, 127, 13762–13763; (e) Ceccacci, F.; Cruciani, O.; Diociaiuti, M.;
Galantini, L.; Formisano, G.; Lindner, W.; Mancini, G.; Villani, C. Tetrahedron:
Asymmetry 2006, 17, 1603–1608; (f) Ceccacci, F.; Giansanti, L.; Levi Mortera, S.;
Mancini, G.; Sorrenti, A.; Villani, C. Bioorg. Chem. 2008, 36, 252–254; (g)
Ceccacci, F.; Giansanti, L.; Mancini, G.; Mencarelli, P.; Sorrenti, A. New J. Chem.
2007, 31, 86–92; (h) Bombelli, C.; Borocci, S.; Lupi, F.; Mancini, G.; Mannina, L.;
Segre, A. L.; Viel, S. J. Am. Chem. Soc. 2004, 126, 13354–13362; (i) Andreani, R.;
Bombelli, C.; Borocci, S.; Lah, J.; Mancini, G.; Mencarelli, P.; Vesnaver, G.;
Villani, C. Tetrahedron: Asymmetry 2004, 15, 987–994; (j) Bella, J.; Borocci, S.;
Mancini, G. Langmuir 1999, 15, 8025–8031; (k) Bombelli, C.; Bernardini, C.;
Elemento, G.; Mancini, G.; Sorrenti, A.; Villani, C. J. Am. Chem. Soc. 2008, 130,
2732–2733.
Compound 2c, a pale yellow solid, was obtained from 7c in 90%
yield, following the same procedure described for 2a (TLC, CC:
CHCl3/CH3OH/H2O = 64:34:2, crystallization from t-BuOMe, Calcd
for C40H68N2O6: C, 71.39; H, 10.12; N, 4.17. Found: C, 71.10; H,
10.40; N, 3.88). 1H NMR (CD3OD): 6.791 (4H, s, Ar); 3.90–3.65
(8H, m, –CH2OAr,
a, d); 3.27–2.94 (6H, m, –CH2N, d); 2.47–2.31
(2H, m, b); 2.17–1.82 (6H, m, b,
c
); 1.78–1.58 (8H, m, –CH2CH2OAr,
–CH2CH2N); 1.50–1.21 (32H, m, –(CH2)8–). 13C NMR (CD3OD):
173.72; 154.63; 116.45; 70.65; 69.61; 56.70; 55.95; 30.70; 30.65;
30.62; 30.53; 30.29; 30.25; 27.66; 27.18; 27.01; 24.36.
3.5.10. 12-Phenoxydodecan-1-ol 6d
Compound 6d, a white solid, was obtained from phenol 5d in
92% yield, following the same procedure described for 6a. 1H
NMR (CDCl3): 7.35–7.20 (2H, m, Ar), 6.95–6.80 (3H, m, Ar), 3.943
(2H, t, ArOCH2, J = 6.6 Hz), 3.630 (2H, t, CH2OH, J = 6.6 Hz), 1.90–
1.68 (2H, m, ArOCH2CH2), 1.62–1.20 (18H, m, –(CH2)9). 13C NMR
(CDCl3): 159.11, 129.38, 120.44, 114.48, 67.86, 63.05, 32.80,
29.56, 29.43, 29.40, 29.29, 26.06, 25.74.
3.5.11. 12-Phenoxydodecanal 7d
4. Navon, G.; Frank, S.; Kaplan, D. J. Chem. Soc., Perkin Trans. 2 1984, 1145–
1149.
5. (a) Aguiar, J.; Carpena, P.; Molina-Bolívar, J. A.; Carnero Ruiz, C. J. Colloid
Interface Sci. 2003, 258, 116–122; (b) Kalyanasundaram, K.; Thomas, J. K. J. Am.
Chem. Soc. 1977, 9, 2039–2044; (c) Ananthapadmanabhan, K. P.; Goddard, E. D.;
Turro, N. J.; Kuo, P. L. Langmuir 1985, 1, 352–355.
6. Ceccacci, F.; Mancini, G.; Mencarelli, P.; Villani, C. Tetrahedron: Asymmetry
2003, 14, 3117–3122.
7. McDonagh, A. F.. In The Porphyrin; Dolphin, D., Ed.; Academic Press: New York,
1979; Vol. 6, pp 293–491. Chapter 5.
Compound 7d, a white solid, was obtained from phenol 6d in
87% yield, following the same procedure described for 7a. 1H
NMR (CDCl3): 9.753 (1H, t, CHO, J = 1.8 Hz), 7.34–7.15 (2H, m,
Ar), 7.05–6.80 (3H, m, Ar), 3.939 (2H, t, ArOCH2, J = 6.6 Hz), 2.410
(2H, dt, CH2OH, J = 1.8 Hz, J = 7.3 Hz), 1.84–1.70 (2H, m, Ar-
OCH2CH2), 1.70–1.50 (2H, m, CH2CH2CHO), 150–1.20 (14H, m, –
(CH2)7). 13C NMR (CDCl3): 203.00, 159.12, 129.40, 120.44, 114.48,
67.84, 43.92, 29.53, 29.50, 29.40, 29.35, 29.29, 29.16, 26.06, 22.09.
8. (a) Lightner, D. A.; Gawromski, J. K.; Gawromska, K. J. Am. Chem. Soc. 1985, 107,
2456–2461; (b) Lightner, D. A.; Gawromski, J. K.; Wijekoon, W. M. D. J. Am.
Chem. Soc. 1987, 109, 6354–6362.
3.5.12. (2S)-1-(12-Phenoxydodecyl)-pyrrolidine-2-carboxylic
acid 4
9. Tobler, E.; Lammerhofer, M.; Lindner, W.; Mancini, G. Chirality 2001, 13, 641–
647.
10. Koppel, D. E. J. Chem. Phys. 1972, 57, 4814–4820.
11. Provencher, S.; Hendrix, J.; De Maeyer, L.; Paulussen, N. J. Chem. Phys. 1978, 69,
4273–4276.
12. Berne, B. J.; Pecora, R. Dynamic Light Scattering with Applications to Chemistry,
Biology and Physics; Wiley: New York, 1976.
13. Hébrant, M.; Burgoss, P.; Assfeld, X.; Joly, J.-P. J. Chem. Soc., Perkin Trans. 2 2001,
998–1004.
14. Dess, D. B.; Martin, J. C. J. Org. Chem. 1983, 48, 4155–4156.
Compound 4, a pale yellow solid, was obtained from 7d in 90%
yield, following the same procedure described for 2a (TLC, CC:
CHCl3/CH3OH/H2O = 64:34:2; crystallization from MeOH/t-BuOMe.
Calcd for C23H37NO3: C, 73.56; H, 9.93; N, 3.73. Found: C, 73.45; H,
10.01; N, 3.65). 1H NMR (CDCl3): 7.28–7.16 (2H, m, Ar), 6.92–6.78
(3H, m, Ar), 4.04–3.80 (3H, om, ArOCH2, d), 3.72–3.60 (1H, m,
a),